Join us next week for the 2026 Accelerated Review in Medical Oncology, featuring expert faculty from across @MSKCancerCenter and the @MSK_DeptOfMed. Designed to support preparation for the #ABIM #MedicalOncology certification and recertification examinations, this high-yield program features concise micro-lectures, an interactive board question review, and a course workbook with summary notes to support exam preparation. Complimentary for fellows, with discounted rates for select groups. Learn more and register: bit.ly/ARMO2026

We’re pleased to welcome @MarcCarrier1, of the University of Ottawa, as this year’s keynote speaker for the 2026 @MSKCancerCenter State of the Art in Benign Hematology, Hemostasis, and Thrombosis Symposium, taking place this Friday, October 16. For full program details and registration, visit: bit.ly/BenignHeme2026

At MSK, rhabdomyosarcoma is not rare to us. During our one-day symposium this Monday, October 19, Rhabdomyosarcoma 2026: Advancing Science, Improving Outcomes, experts will share insights into the critical balance between optimizing treatment outcomes and minimizing toxicities associated with chemotherapy and radiation therapy. Discussions will also highlight innovative surgical and radiation techniques aimed at mitigating long-term side effects and improving patient outcomes. Join us in person at @MSKCancerCenter or virtually to learn more about the latest advances and evolving approaches to rhabdomyosarcoma care. Learn more and register at bit.ly/MSKRhabdoCME

Join us next week for two days focused on the latest advances, evolving treatment strategies, and key clinical questions in #ProstateCancer care. Through tumor boards, panel discussions, and head-to-head debates, multidisciplinary experts from @MSKCancerCenter and guest speakers, @Chris_Barbieri1 and @mishabeltran, will explore the full continuum of care — from screening, biomarkers, and advanced imaging to active surveillance, focal therapy, high-risk and metastatic disease, PSMA PET, radioligand therapy, PARP inhibition, and precision treatment strategies. We hope to see you in New York or virtually, October 8–9. Learn more and register: bit.ly/Prostate2026CME #MSKprostateCME

Last week, we were pleased to welcome participants onsite and virtually for the 4th Annual Pulmo-Oncology Symposium @MSKCancerCenter. As the field of pulmo-oncology continues to evolve, the program brought together experts from multiple disciplines to share the latest advances in cancer therapies and best practices in the evaluation and management of lung disease in patients with cancer. Thank you to our outstanding faculty, speakers, and participants for contributing to a day of thoughtful discussion, collaboration, and learning. Missed the live symposium? Register for on demand access: bit.ly/2026PulmoOncOnDemand Guest Faculty: Gerard Silvestri, MD, MS (Keynote Speaker) Erica Altschul, MD Alexander Geyer, MD Jennifer Possick, MD Michael Pritchett, DO, MPH MSK Faculty: Leontine van Elden, MD, PhD (@EldenVan) Elizabeth Yogiaveetil, MD Christina Hess, AGACNP-BC Shanan Barua, MD Michelle Cavuoto, MA, RN, OCN Mohit Chawla, MD, FCCP Catherine Oberg, MD (@IP_DOC) Gopi Patel, MD Tafadzwa Chaunzwa, MD (@TLChaunzwaMD) Robert Daly, MD, MBA Andrew Harris, MD Amnah Khalid, MD Hope Miodownik, MD Rastko Rakocevic, MD, MSc Jessica Ross, MD Narek Shaverdian, MD Timothy Tiutan, MD #MSKPulmoOncCME

Join us this Saturday for a one-day virtual course @MSKCancerCenter offering an evidence-based overview of psychopharmacologic approaches to managing key disorders and symptoms experienced by adults with cancer, with a focus on supporting quality of life across the cancer care continuum. Learn more and register: bit.ly/Psychopharm2026 Topics will include: 🔹Depressive and Anxiety Disorders 🔹Delirium 🔹Sleep Disorders 🔹Cancer-Related Fatigue 🔹Pain 🔹Weight and Appetite Loss 🔹Cancer- and Treatment-Related Cognitive Changes 🔹Novel Psychopharmacologic Interventions 🔹Ketamine and Esketamine for Depression 🔹The Essential Role of Clinical Social Work in Caring for the Whole Patient AMA PRA Category 1 Credit™, ABIM MOC, ANCC nursing, NYS Psychology, and NYS Social Work credits available.

Join us next week for the 2026 Pulmo-Oncology Symposium @MSKCancerCenter, a state-of-the-art interdisciplinary program focused on the evolving care of patients with cancer who experience pulmonary comorbidities and complications of cancer and its therapies. Attend live on Sept. 25 — in person at MSK or virtually — or register for on demand access. Topics will cover: — Pulmonary complications, including treatment-related pulmonary hypertension, graft-versus-host disease, and bronchiectasis — Advances in lung cancer care, including novel systemic therapies and bronchoscopic ablation — Treatment-related toxicities, including radiation-induced lung injury and severe immune checkpoint inhibitor pneumonitis — Emerging technologies and approaches, including AI, telehealth, and health education in the age of social media 🔗 bit.ly/PulmoOnc2026 @EldenVan @IP_DOC @TLChaunzwaMD

National Online Learning Day was recognized yesterday, September 15, highlighting the growing role of digital education and access to online learning. At @MSKCancerCenter, we offer a growing library of accredited on demand programs covering a wide range of topics in cancer care. This fall, many of our upcoming programs will also be available on demand following the live event. You can register for the on demand option in advance and will be notified when course materials are available. Explore our on demand library and upcoming accredited educational opportunities at msk.org/cme. Currently available on demand: 🔹Advances in Dermatologic Imaging 🔹Pulmo-Oncology Symposium 🔹Advances in Colorectal Oncology 🔹Diagnostic Excellence for Primary Care Providers 🔹Rhabdomyosarcoma 🔹Emergencies in the Cancer Patient 🔹Pediatric and Young Adult Brain & Spine Tumor Care 🔹Achieving Health Equity in Cancer Care 🔹Advancing Surgical Oncology 🔹Cardio-Oncology Symposium 🔹Implementation Science in Aging & Cancer 🔹Symposium on Lymphoma 🔹Geriatric Oncology Symposium 🔹Radiologic Interpretation in Oncology 🔹Pathology of Neoplastic Diseases 🔹Update in Hematology & Medical Oncology 🔹Translating Evidence to Action 🔹Immunotherapy in the Oncology Population 🔹Advancing Osteosarcoma Care 🔹World Hospice & Palliative Care 🔹Thoracic Pathology Course 🔹Critical Care Oncology Symposium 🔹Pediatric Critical Care Oncology 🔹Invasive Lobular Breast Cancer Training Series 🔹Ageism in Healthcare 🔹JEM Journal-Based CME #NationalOnlineLearningDay #MSKCME

Join us next week for two days of comprehensive training in clinical cancer genetics, led by experts from @MSKCancerCenter and invited keynote speakers. The course will provide a strong foundation in cancer genetics, explore the clinical implications of genetic testing for patient care, and highlight emerging advances in cancer genomics. Attend in person at MSK or virtually, September 17–18. Learn more and register: bit.ly/HereditaryCancerGenti…

Tomorrow, we bring together leading experts and perspectives to examine where the field of brain metastases stands today — and where it is headed next. We’ll open the 2026 Advanced Therapeutics for Brain Metastasis symposium with two keynote presentations that set the stage for the day. Dr. Matthias Preusser will provide a broad perspective on the evolving field — from population-level epidemiology to the emerging era of precision medicine. Julia Maués will share the patient perspective on living with brain metastases, bringing an essential voice to the clinical and scientific discussions that will follow throughout the program. Join us virtually September 9 for this complimentary symposium. View the program and register free: bit.ly/BrainMets2026 @itsnot_pink @Dr_N_Moss @MSKCancerCenter @MSKNeurosurgery

Leptomeningeal disease remains one of the most challenging clinical scenarios in neuro-oncology — and one where the science is rapidly evolving. At our complimentary virtual symposium, Advanced Therapeutics for Brain Metastasis, we’ve dedicated a full session to the latest advances in this complex area. Michael Weller, MD, will explore the biology, imaging, and pathophysiology of leptomeningeal disease, while Chetan Bettegowda, MD, PhD, will discuss advances in CSF liquid biopsy and biomarkers. Join us virtually on September 9 to hear the latest insights and emerging approaches shaping the field. View the full program and register free at: bit.ly/BrainMets2026 @Dr_N_Moss @BettegowdaMDPHD

Join experts from MSK Kids and the MSK Department of Neurosurgery for a complimentary virtual symposium focused on the latest advances in multidisciplinary care for pediatric and young adult brain and spinal tumors at @MSKCancerCenter. The program will explore innovations across the continuum of care, including neurosurgical management, molecular diagnosis, precision therapies and emerging clinical trials, radiation oncology, rehabilitation, cognitive monitoring, integrative medicine, and long-term survivorship. Registration is complimentary, with options to participate live virtually or access the recorded program on demand following the symposium. Learn more and register: bit.ly/PedsNeuroOnc MSK Faculty Andrew Kobets, MD, MHS, FAANS, FCNS Matthias Karajannis, MD, MS Sameer Farouk Sait, MBBS Zoltan Antal, MD Tejus Bale, MD, PhD Deborah Cassidy, DO Yasmin Khakoo, MD, FCNS, FAAN, FAAP Nirupa Raghunathan, MD, MS Stephen Sands, PsyD Suzanne Wolden, MD, FACR

Join us on November 13 for a complimentary conference focused on advancing health equity in cancer care and improving outcomes for underserved populations. This year’s program will explore cancer prevention in underserved communities, with expert perspectives on environmental exposures, tobacco cessation, nutrition, physical activity, and strategies to reduce disparities across the cancer prevention continuum. Registration is complimentary, with options to attend live @MSKCancerCenter or access the recorded program on demand following the event. 🔗bit.ly/2026HEC @JamaicaHospital @FHMC_NYC @RLCCC @MeliD32 @FiyinfoluB @JoshuaBudhu @CDebyaniPhD @sabz611 @Neil_Iyengar @anavasac @UrviShahMD @cardismith

Nearly 40% of men and women will be diagnosed with cancer in their lifetime, yet fewer than 20% of cancers are detected through recommended preventive screening. From recognizing the earliest signs of cancer to managing the long-term needs of survivors, general practice providers play a critical role across the cancer care continuum. This new, intensive course from @MSKCancerCenter is designed for PCPs, APPs, and nurse navigators and will provide practical guidance on cancer screening and early detection, diagnostic testing and triage, incidental findings and surveillance, treatment-related complications, and survivorship care. Learn more: bit.ly/DiagnosticExcellenceC… Course Planners: @PamelaJohnsonMD @lonnyyarmus @DrScalabrino

We’re pleased to celebrate the 10th anniversary of the @MSKCancerCenter Advances in Colorectal Oncology Symposium. Join leading experts for a focused look at the latest advances in surgical and multidisciplinary management of #ColorectalCancer, with insights into emerging technologies and evolving approaches shaping clinical care. View the program and register: bit.ly/MSKColorectalCME @jgarciaaguilar @AndreaCercek @DrPaulRomesser @RonaYaeger @geo_karag @abbassmohd @haydencrane5 @KarunaMDPhD @marc_gollub @malihanusr @EmmanouilPappou @segaln

At our complimentary virtual symposium, Advanced Therapeutics for Brain Metastasis course, the Therapeutic Frontiers session will provide disease-specific updates across key tumor types associated with brain metastases. Carey Anders, MD, will discuss advances in breast cancer; Hussein Tawbi, MD, PhD, will review systemic therapies for melanoma brain metastases; and Gregory Riely, MD, PhD, will highlight the latest developments in thoracic oncology. These are three areas where the pace of change has been remarkable. Join us virtually on September 9 to explore recent advances and their implications for clinical decision-making. Register for free at bit.ly/BrainMets2026 @HTawbi_MDPhD @CareyAnders1 @Dr_N_Moss @MSKCancerCenter